Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.3400
-0.0089 (-2.55%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Vaxart Employees
Vaxart had 105 employees as of December 31, 2024. The number of employees decreased by 4 or -3.67% compared to the previous year.
Employees
105
Change (1Y)
-4
Growth (1Y)
-3.67%
Revenue / Employee
$273,333
Profits / Employee
-$637,600
Market Cap
78.39M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
VXRT News
- 2 days ago - Vaxart to Present at World Vaccine Congress Washington 2025 on April 23 - GlobeNewsWire
- 2 days ago - Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 - GlobeNewsWire
- 22 days ago - Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Vaxart, Inc. (VXRT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Vaxart Provides Business Update and Reports Full Year 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate - GlobeNewsWire
- 6 weeks ago - Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults - GlobeNewsWire
- 3 months ago - Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial - GlobeNewsWire